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Abstract
AIM: To study the epidemiologic indicators of uptake 
and characteristic colonoscopic findings in the Croatian 
National Colorectal Cancer Screening Program. 
METHODS: Colorectal cancer (CRC) was the sec-
ond leading cause of cancer mortality in men (n  = 
1063, 49.77/100  000), as well as women (n  = 803, 
34.89/100  000) in Croatia in 2009. The Croatian Na-
tional CRC Screening Program was established by the 
Ministry of Health and Social Welfare, and its imple-
mentation started in September, 2007. The coordinators 
were recruited in each county institute of public health 
with an obligation to provide fecal occult blood testing 
(FOBT) to the participants, followed by colonoscopy in 
all positive cases. The FOBT was performed by hyper-
sensitive guaiac-based Hemognost card test (Biognost, 
Zagreb). The test and short questionnaire were deliv-
ered to the home addresses of all citizens aged 50-74 
years consecutively during a 3-year period. Each par-
ticipant was required to complete the questionnaire and 
send it together with the stool specimen on three test 
cards back to the institute for further analysis. About 4% 
FOBT positive cases are expected in normal risk popu-
lations. A descriptive analysis was performed.
RESULTS: A total of 1  056  694 individuals (born be-
tween 1933-1945 and 1952-1957) were invited to 
screening by the end of September 2011. In total, 
210  239 (19.9%) persons returned the envelope with 
a completed questionnaire, and 181 102 of them re-
turned it with a correctly placed stool specimen on 
FOBT cards. Until now, 12  477 (6.9%), FOBT-positive 
patients have been found, which is at the upper limit 
of the expected values in European Guidelines for 
Quality Assurance in CRC Screening and Diagnosis 
[European Union (EU) Guidelines]. Colonoscopy was 
performed in 8541 cases (uptake 66%). Screening has 
identified CRC in 472 patients (5.5% of colonoscopied, 
3.8% of FOBT-positive, and 0.26% of all screened 
individuals). This is also in the expected range accord-
ing to EU Guidelines. Polyps were found and removed 
in 3329 (39% of colonoscopied) patients. The largest 
number of polyps were found in the left half of the 
colon: 64% (19%, 37% and 8% in the rectum, sigma, 
and descendens, respectively). The other 36% were 
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detected in the proximal part (17% in the transverse 
colon and 19% in ceco-ascending colon). Small polyps 
in the rectum (5-10 mm in diameter), sigmoid and de-
scending colon were histologically found to be tubular 
adenomas in 60% of cases, with a low degree of dys-
plasia, and 40% were classified as hyperplastic. Polyps 
of this size in the transverse or ceco-ascending colon 
in almost 20% had a histologically villous component, 
but still had a low degree of dysplasia. Polyps sized 
10-20 mm in diameter were in 43% cases tubulovil-
lous, and among them, 32% had areas with a high de-
gree of dysplasia, especially those polyps in the ceco-
ascending or transverse part. The characteristics of the 
Croatian CRC Screening National Program in the first 3 
years were as follows: relatively low percentage of re-
turned FOBT, higher number of FOBT-positive persons 
but still in the range for population-based programs, 
and higher number of pathologic findings (polyps and 
cancers).
CONCLUSION: These results suggest a need for inter-
vention strategies that include organizational changes 
and educational activities to improve awareness of CRC 
screening usefulness and increase participation rates.
© 2012 Baishideng. All rights reserved. 
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INTRODUCTION
The incidence of  colorectal cancer (CRC) has been in-
creasing during recent decades, and the lifetime risk for 
CRC in industrialized countries is about 5%[1]. CRC is 
the one of  major global public health problems, with ap-
proximately 950  000 newly diagnosed cases each year[2]. 
CRC is a good candidate for screening, because it is a 
disease with high prevalence, has recognized precur-
sor lesions, and early treatment is beneficial. Reducing 
the number of  deaths from CRC depends on detecting 
and removing precancerous colorectal polyps, as well 
as detecting and treating the cancer in its early stages[3]. 
Approximately 3000 new cases of  CRC are diagnosed 
annually in Croatia and around 1900 people die of  CRC 
each year. According to the Croatian Cancer Registry, in 
2008 there were 1255 (54.5/100  000) women and 1819 
(85.1/100  000) men with newly diagnosed CRC[4]. The 
incidence and crude mortality rates from CRC have in-
creased since the 1970s (Figure 1), and the incidence and 
mortality increase considerably after the age of  50 years. 
In Croatia it was the second leading cause of  cancer 
mortality in men (n = 1063, 49.77/100  000), as well as 
in women (n = 803, 34.89/100  000) in 2009[5]. CRC con-
stitutes 12.9% of  all newly diagnosed carcinomas in the 
European population (men 12.8%, women 13.1%) and 
accounts for 12.2% of  deaths caused by malignancy[6]. 
Compared to other European Union (EU) members 
where organized population screening programs have 
existed for several years, in Croatia the standardized 
mortality rates of  CRC are higher, but still lower than 
those in some western countries (Figure 2). The join-
point analysis showed that CRC in men in Croatia has 
increasing trends of  both incidence calculated as esti-
mated annual percent change (EAPC 2.9%) and mortal-
ity (EAPC 2.1%), while in women, the increase in inci-
dence was not significant, but mortality rates in the last 
15 years showed a significant increase (EAPC 1.1%)[7]. 
A number of  randomized trials and one Cochrane 
review provided strong evidence that fecal occult blood 
test (FOBT) followed by colonoscopy, if  offered every 
2 years, reduced mortality rates associated with CRC by 
16%[8,9]. In the Czech Republic the rates were higher in 
a previous period, but, owing to the implementation of  
organized screening, in 2007 they became lower than in 
Croatia (Figure 3)[10,11]. Hungary is one of  the transitional 
countries with higher mortality than that in Croatia, and a 
pilot program has now been completed there and prepa-
rations for a nation-wide program are ongoing[12,13]. The 
EU council recommendation of  December 2003, stated 
that screening for CRC by FOBT in men and women 
aged 50-74 years met the requirements of  the public 
health program. 
The Croatian Cancer Registry is a nation wide popu-
lation-based registry, covering over 90% of  cancer cases 
in the country. The existence of  cancer registry allows us 
to evaluate effects of  screening on changes in CRC in-
cidence, which is expected to be higher for the first few 
years. CRC is also expected to be increasingly detected at 
an earlier stage owing to the screening program. There-
fore, after 5 years, it is expected that our national mortal-
ity data will show a reduction in CRC mortality. The aim 
of  this paper is to describe the population-based screen-
ing program for CRC whose implementation started 
during 2008. The political decision to launch it was made 
by the Ministry of  Health and Social Welfare at the end 
of  2007 according to the previously published propos-
al[14]. Due to some unexpected organizational difficulties, 
it is planned that first round will be finished during 2011. 
MATERIALS AND METHODS
Program organization: the Republic of  Croatia is divided 
in 20 counties plus the capital city of  Zagreb and there 
is one public health institute in each county and city. In 
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each local public health institute there is a coordinator 
nominated for the National Screening Program. At the 
national level, a coordinator from the Croatian National 
Public Health Institute has been nominated, and all 22 
coordinators are members of  the Committee for Pro-
gram Performance. An Expert Committee has also been 
nominated by the Minister of  Health and Social Welfare 
with the main task to evaluate professional qualification 
of  colonoscopists included in the National Program 
and to attend to other issues during the program perfor-
mance. The Committee consists of  project co-ordinators 
from the Ministry of  Health and Social Welfare, the Na-
tional Co-ordinator from the Croatian National Public 
Health Institute, three members of  the Croatian Gastro-
enterology Society, and representatives of  oncologists 
and primary care physicians. The co-ordinators (medical 
specialists in epidemiology or in public health) in each 
local institute of  public health are obliged to ensure 
performance of  FOBT, followed by colonoscopy in all 
positive cases. They also ensure the collection of  data on 
colonoscopic diagnosis, histopathologic findings, cancers 
and polyps, and to keep records about tests performed 
in each person. If  a patient is diagnosed with CRC, 
the co-ordinator’s obligation is to inform the patient’
s primary care physician. The co-ordinator also has to 
provide the answers to the questionnaire for each person 
tested in a web-based database, and to send the report 
with cumulative data about diagnostic findings to the 
national co-ordinator. Upon the receipt of  the data, the 
national co-ordinator compiles all data and, according 
to results, controls the performance in each county. A 
national report is sent twice monthly to all members of  
the Expert Committee and to the member in the Min-
istry of  Health and Social Welfare. The main indicators 
available from these reports include: uptake (compli-
ance), number of  persons who correctly applied speci-
mens on cards, number of  persons with positive FOBT, 
number of  patients invited to colonoscopy, number of  
colonoscopies performed, number of  patients in whom 
CRC was diagnosed, number of  patients where polyp 
(polyps) was detected, number of  patients where other 
disease was found (e.g., diverticula, inflammatory bowel 
diseases, hemorrhoids). The test and short questionnaire 
were planned to be delivered at the home addresses of  
all citizens aged 50-74 years consecutively during 3 years. 
So far, the population born between 1933-1945 and 
1952-1957 has been invited. Each participant was re-
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Figure 1  Incidence and crude mortality rate of colorectal cancer in Croa-
tia from 1970 to 2009 year. 
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Figure 2  Incidence and mortality rates of colorectal cancer in European 
countries[40]. 
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Figure 3  Comparison of standardized mortality rate of colorectal cancer 
in Croatia and some other European Union countries (source: World 
Health Organization, European Mortality Database, Health for All 2011). 
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fied CRC in 472 patients (3.6% of  FOBT-positive and 
0.26% of  all individuals screened through the program). 
Polyps have been found and removed in 3329 (39% of  
FOBT-positive) patients (Table 1).
Unfortunately, there were great differences in the per-
centage of  returned FOBTs between Croatian counties 
as well as in the number of  pathologic findings (Table 
2). Generally, people from continental counties returned 
FOBT more frequently (13.8%-30.7%), then those from 
the coastal areas (10.7%-21.7%). The number of  CRCs 
identified varied from 1.0% to 12.2% of  all colonoscopy 
participants (Table 2). There are several reasons for such 
differences; only partially this depends on variation in 
CRC and polyp incidence. Probably, the main reason can 
be attributed to the unequal experience and skills of  the 
endoscopic teams, as well as the inadequate number of  
endoscopic instruments and equipment in some counties. 
An additional cause can be found in the greater response 
of  people who had some symptoms of  disease (e.g., 
pain, discomfort, irregular stool evacuation). Some data 
support this thesis because among false-positive FOBT 
results for CRC detection, hemorrhoids, inflammatory 
bowel disease and diverticula in 27.5%, 3.7% and 14.6% 
of  cases, respectively, were found, as well as other chang-
es which can cause positive FOBT results. 
We found some differences in characteristics of  
polyps according to localization and size (Table 3). The 
largest number of  polyps were found in the left half  
of  the colon: 64% (19%, 37% and 8% in the rectum, 
sigmoid, and descending, respectively). The other 36% 
were detected in the proximal part (17% in the transverse 
colon, and 19% in the ceco-ascending). During screening 
colonoscopy, all polyps up to 15 mm in diameter were 
removed; 80% of  those up to 20 mm in diameter, and 
50% of  those larger than 20 mm, were later removed by 
endoscopy or surgery.
Small polyps in the rectum (5-10 mm in diameter), 
sigmoid and descending colon were histologically tubular 
adenomas in 60% of  cases, with a low degree of  dys-
plasia, and 40% were classified as hyperplastic. Polyps 
of  this size in the transverse or ceco-ascending part in 
almost 20% had a histologically villous component, but 
still were at a low degree of  dysplasia. Forty-three percent 
of  polyps 10-20 mm in diameter were tubulovillous, and 
among these 32% had areas with a high degree of  dys-
plasia, especially those polyps in the ceco-ascending or 
transverse part.
Polyps over 20 mm in the rectum and sigmoid were 
tubular adenomasin 48% of  cases, while others, as well as 
all the larger polyps in transverse or coecoascendent part 
were tubulovillous, villous or in 41% with high grade dys-
plasia, and 8% intramucosal carcinoma.
DISCUSSION
In order to ensure health-care equality, we covered 100% 
of  the available population aged 50-74 years, and 84% 
of  them received the test package at their home address. 
quired to complete the questionnaire, and send it togeth-
er with the stool specimen on three test cards (each with 
four windows) by prepaid mail to the institute for further 
analysis. Most current FOBT methods are guaiac-based 
tests, as established more than a century ago. The pseu-
doperoxidase activity of  heme converts colorless guaiac 
to a blue color in the presence of  hydrogen peroxide. 
The FOBT is performed by guaiac-based HemoGnost 
card (Biognost, Zagreb, Savica-Šanci) test with a detec-
tion limit of  0.252-0.348 mg hemoglobin/g stool. Cards 
were designed for easy mailing, with a space to write the 
name of  the participant and the date of  fecal sampling. 
Each card had four windows for stool specimens. A leak 
proof  storage and a return envelope were included. The 
manufacturer’s instructions were closely followed con-
cerning dietary restrictions and advice about taking sam-
ples. Dietary restrictions 3 d before and during sampling 
include avoiding raw meat, liver or blood dishes and 
large amounts of  supplemental vitamin C (> 250 mg/d). 
Last year, in order to encourage people to take the test, 
printing the strip-form instruction on the back of  the 
manufacturer’s instructions was arranged. Colonoscopies 
were done in colonoscopic units (38 of  them in Croatia) 
by well-trained and experienced colonoscopists.
Statistical analysis
A descriptive analysis of  epidemiologic indicators was 
done. Results were compared with the reference range in 
European Guidelines for Quality Assurance in Colorectal 
Cancer Screening and Diagnosis[15].
RESULTS
By the end of  2011 a total of  1 056 694 (84% of  eligible) 
individuals (born between 1933-1945 and 1952-1957) 
were invited to screening. Among them, 210 239 persons 
(19.9%) returned the envelope with the completed ques-
tionnaire and 181  102 of  them returned correctly com-
pleted FOBT cards. Until now, 12  477 positive FOBT 
patients have been found (6.9%). Colonoscopy was per-
formed in 8541 cases (uptake 66%). Screening has identi-
Table 1  Epidemiologic indicators of colorectal cancer 
screening uptake and diagnostic findings
Indicator n (%) Relative to issue 
Invited 1 056 694 (84.0)   Eligible 
Returned envelopes    210 239 (19.9)   Invited 
Returned with specimen    181 102 (17.1)   Invited 
Positive FOBT      12 477 (6.9)     Returned with specimen and 
examined 
Colonoscopy done         8541 (66.0)   Positive FOBT 
Hp confirmed Ca           472 (5.5)     Colonoscopied 
Patients with polyp(s)         3329 (39.0)   Colonoscopied 
Diverticula         1238 (14.6)   Colonoscopied 
IBD and other findings           320 (3.7)     Colonoscopied 
Hemorrhoids         2345 (27.5) Colonoscopied 
FOBT: Fecal occult blood test; Hp: Histopathologically; Ca: Carcinoma; 
IBD: Inflammatory bowel disease. 
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Sometimes in our program, we were faced with prob-
lems such as a lack of  educated colonoscopists and/or 
equipment in some counties. However, this also makes 
it possible for us to test feasibility in this part of  the na-
tional health-care system and to plan program costs and 
the additional resources needed in leading time (mainly 
colonoscopies and education of  population). This study 
of  Croatian colonoscopic practice indicates that there are 
centers with practice of  the highest quality, but consider-
able effort is required to improve the overall quality of  
colonoscopy. High quality of  endoscopic service, early 
training, regular refresher courses, and continuous audit 
of  standards at local and national levels must be a priority 
for all endoscopists performing colonoscopy[16].
Additional efforts must be made to improve the qual-
ity of  FOBT performance in public health institutes in 
order to avoid false positives.
Another problem is increasing the uptake, which is in 
our country significantly lower for CRC than for breast 
cancer (the uptake for mammography is up to 70%). 
On one hand, this issue results from unwillingness to 
take stool specimens and, on the other hand, from non- 
compliance with avoiding complicated food and therapy 
restriction before testing. In order to increase the uptake, 
newly written recommendations by the Group for Qual-
ity Control of  the International CRC Network support 
the decision that the procedure and prescriptions have 
to be simplified, so that they can be changed for the next 
cycle immediately[15]. We are aware that guaiac FOBT 
shows notable variations in the performance characteris-
tics between different studies[17]. These differences most 
likely reflect the different populations tested and the 
methods for identifying neoplasia. Indeed, from the first 
results by Allison et al[17] and Greenberg et al[18] to meta-
analysis by Soares-Weiser et al[19], different sensitivities 
for the same tests in different populations or conditions 
have been reported[20]. In the same reports, some ad-
vantages and disadvantages of  immuno-FOBT are dis-
cussed. In the process of  decision making on which test 
to choose for the Croatian Program, we considered the 
arrangement of  mailing the tests, time from taking speci-
mens to testing, and relatively high surrounding temper-
atures in almost half  a year which all can influence the 
accuracy of  immuno-FOBT[21]. So, we have decided that 
Table 2  Uptake, positive fecal occult blood test and colorectal cancer diagnosed through screening program in Croatian counties
County Invited 
(n)
Uptake-
FOBT (%)
Positive Percentage of pos. 
FOBT relative to 
tested persons (%)
Colonoscopied 
persons (n )
Diagnosed 
CRC (n)
Percentage of CRC 
relative to FOBT 
pos. persons (%)
Percentage of CRC 
relative to colonscopied 
persons (%)
Bjelovarsko-bilogorska      29 763 24.0   385   7.8   223   14 3.6   6.3
Brodsko-posavska      39 586 19.2   526   8.8   431   24 4.4   5.6
Dubrovačko-neretvanska      28 971 20.2   318   7.3     41     5 1.6 12.2
Istarska      52 324 19.1   757   7.6   600     6 0.8   1.0
Karlovačka      37 301 25.4 1107   8.7   380   19 3.6   5.0
Koprivničko-križevačka      26 573 19.0   356   7.3   104   10 2.7   9.6
Krapinsko-zagorska      29 440 21.2   478   8.9   334   29 6.1   8.7
Ličko-senjska      16 711 13.8   647 23.9   281     7 1.9   2.5
Međimurska      24 965 30.7   790 11.6   703   39 4.9   5.5
Osiječko-baranjska      75 823 19.1 1369   9.9   803   58 4.2   7.2
Požeško slavonska      19 997 28.7   401   9.8   251   11 2.7   4.4
Primorsko-goranska      78 055 21.7   905   4.1   383   41 6.3 10.7
Sisačko-moslavačka      50 441 18.3   703   8.1   585   22 3.1   3.8
Splitsko-dalmatinska    103 659 14.6 1287   9.0   848   42 3.3   5.0
Šibensko-kninska      32 845 10.7   160   5.0   140   10 6.3   7.1
Varaždinska      38 462 21.3   522   6.5   408   12 2.3   2.9
Virovitičko-podravska      21 176 18.7   299   9.1   193     7 2.3   3.6
Vukovarsko-srijemska      45 562 22.2   633   9.1   483   17 2.7   3.5
Zadarska      45 505 16.3   582   8.2   496   23 4.0   4.6
Zagreb town    190 200 22.3   361   2.9   680   62 6.4   9.1
Zagrebačka      69 335 17.2   327   3.1   174   14 3.9   8.0
Total 1 056 694 19.9 12  477   6.9 8541 472 3.8   5.5
FOBT: Fecal occult blood test; CRC: Colorectal cancer; pos.: Positive. 
Table 3  Characteristics of polyps detected through colorectal cancer screening program in Croatia
Part of colon Localization Percent (%) Size 5-10 mm Size 10-20 mm Size ≥ 20 mm
Left Rectum 19 60% tubular adenoma, low degree 
of dysplasia
43% tubulovillous, among them 
32% had areas with a high degree 
of dysplasia, especially in the ceco-
ascending or transverse part
48% tubular adenomas
Sigmoid 37 40% hyperplastic
Descending   8 Tubulovillous and villous
Right Transverse 17 20% villous component, low degree 
of dysplasia
41% with high grade dysplasia
Ceco-ascending 19 8% intramucosal carcinoma
Katičić M et al . Croatian CRC screening program
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guaiac card-based tests are more convenient for screen-
ing in Croatia. Data about higher percentage of  FOBT-
positive persons indicated that the population screened 
so far was not really asymptomatic; people who returned 
tests most frequently had evident symptoms; mostly 
blood in stool or impairment of  bowel discharge, consti-
pation or diarrhea, with or without pain in the distal ab-
domen. Thus, there is a need actively to include the indi-
viduals who are in the “normal and healthy” population. 
This is frequently seen at the start of  every screening 
program[22,23]. It is well known that the effectiveness of  
any screening program depends not only on the diagnos-
tic performance of  the screening, but also on the uptake 
and general acceptance of  the test by the public[23,24]. In a 
field trial, urban-rural differences in the screening uptake 
were detected[25]. Among some other issues, one of  the 
important problems is to find how to improve uptake. 
There is clear evidence in our national program of  early 
diagnosis of  breast cancer, where we reached a 70% up-
take level, that education of  a focused population group 
can increase uptake[25]. We must continue to improve 
awareness that screening for CRC can reduce the mortal-
ity associated with the disease. According to other stud-
ies, compliers with CRC screening are less deprived; they 
have higher education than non-compliers. There is also 
a need to advance knowledge and promote engagement 
of  primary care physicians, according to other data[21]. 
However, the Croatian Adult Health Survey showed that 
self-reported compliance for CRC screening was 4.5% 
for females and 6.1% for males included in study[26]. It is 
obvious that the response in the National Screening Pro-
gram was higher and it depended on the age group of  
the invited population and county. The results of  a con-
trol field trial showed a significantly higher response rate 
to FOBT when given by primary care physicians[27], but, 
unfortunately, in that study a small number of  physicians 
was voluntarily included, precluding us from achieving 
conclusive results on the whole population. In addi-
tion, this experience cannot be easily implemented to 
the whole country due to organizational difficulties and 
presence or absence of  willingness of  physicians to be 
included in organized national screening. The results of  
a population study from Italy confirmed that there is a 
higher response if  the FOBT kit was sent by mail, but in 
non-responders it incurred higher costs[28]. Response to 
screening depends on population education but also on 
willingness of  all included in the program, and it has to 
be carefully planned[29-34]. We still do not have a detailed 
analysis of  costs and possible differences if  the test kit is 
not sent by mail, so this remains to be done for the next 
cycle. 
There are some other reasons for nonparticipation 
which could be targeted in interventions aimed at in-
creasing participation rates in Croatia. For example, it 
may be difficult to make arrangements for colonoscopy 
for people who live on islands and must travel to hospi-
tals in the nearest city on the coast; they feel uncomfort-
able traveling by ferry while prepared for colonoscopy 
and must be near the toilet during that journey. Hence, 
in that case, it might be reasonable to provide a mobile 
colonoscopy service.
Another problem of  CRC screening is people with 
false-positive FOBT results, who occupy time in colo-
noscopic units and represent unnecessary procedures. 
According to our data, most false positive FOBT persons 
(false-positive to CRC but not to bleeding) had hemor-
rhoids or anal fissures, which is consistent with the other 
data[35]. This can be avoided with adequate education of  
the population and active inclusion of  primary care phy-
sicians[36].
Successful intervention strategies include organiza-
tional changes, such as providing reminders to healthcare 
providers or users about screening opportunities, better 
financial support and educational strategies to improve 
awareness and attitudes toward CRC screening[37,38]. In our 
future work we also must think about reducing inequali-
ties related to socio economic position and ethnicity in the 
uptake of  screening (e.g., Roma population).
In conclusion, the main characteristics of  the Croa-
tian CRC National Program are as follows: low percent-
age of  returned FOBTs, a relatively higher number of  
FOBT-positive persons, but still in the range for popula-
tion-based program; and a higher number of  pathologic 
findings (CRC at the upper range and polyps above the 
upper range)[39].
There are many possible strengthening mechanisms 
for this activity, which include multifactorial interventions 
that target more than one level of  the screening process 
and likely can have greater effects. Firstly, much effort 
must be given to population education and mass cam-
paign with whole society inclusion. 
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COMMENTS
Background
Colorectal cancer (CRC) screening by either guaiac or immuno fecal occult 
blood test (FOBT) followed by colonoscopy of all positive patients is recom-
mended worldwide. The main purpose of this screening is to detect CRC in 
early phase, or in pre-cancer phase when polyps can be easily removed by 
colonoscopy. This type of cancer can be prevented and/or diagnosed early, and 
patients can have a better quality of life, and mortality of CRC can be reduced. 
Research frontiers
The implementation of the National CRC Screening Program in Croatia gives 
opportunity for better monitoring uptake of screening and to explore character-
istic colonoscopic findings.
Innovations and breakthroughs
The CRC screening program in Croatia is organized through a network of public 
health institutes and represents good co-operation between public health and 
clinicians. But, there is still a place for improvement.
Applications
Epidemiologic data of screening uptake and characteristic colonoscopic find-
ings compared with other data and also with expected ranges in European 
Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis 
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showed similar values in Croatia, but authors found some differences between 
counties. 
Terminology
FOBT can detect very small amounts of blood in stools, which cannot be seen 
visually without this laboratory test. Patients who have polyps or CRC can be 
detected by this test. Colonoscopy is still the gold standard to make the final 
diagnosis and to remove polyps in order to prevent CRC.
Peer review
This study reported data on the CRC Screening Program in Croatia performed 
with FOBT followed by colonoscopy in positive cases. CRC detection rates 
widely ranged from 2.5% to 12.2% (mean 5.5%). There are several possible 
causes for these differences. Data on the histology of polyps removed at en-
doscopy showed differences between location in colon and size of polyps. 
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